The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Adial Pharmaceuticals, Inc(NASDAQ:ADIL) 
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment o...
Website: http://www.adialpharma.com
Founded: 2010
Full Time Employees: 3
Sector: Healthcare
Industry: Biotechnology
Adial Pharmaceuticals Days Payable Outstanding ttm (DPO)
Adial Pharmaceuticals Op Cashflow Per Share ttm
Adial Pharmaceuticals Free Cashflow Per Share ttm
Adial Pharmaceuticals Cash Per Share ttm
Adial Pharmaceuticals (GAAP) P/E ratio ttm
Adial Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.